Company research / JNJ

JOHNSON & JOHNSON (JNJ)

CIK 0000200406 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated NJ
  • Fiscal year ends Jan 3

For the year ended 2025-12-28, JOHNSON & JOHNSON reported revenue of $94.19B. Revenue grew 6.0% from the prior annual period.

Key ratios (year ended 2025-12-28)

67.9%
Gross margin
28.5%
Net margin
32.9%
Return on year-end equity
6.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-09-04

Headquarters locality: New Brunswick · View on map

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.